TARA HOLT: Open Payments
NPI 1891848560 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 28 payments from 12 companies in 2025. Trend: 2023 $337 · 2024 $567 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Novo Nordisk Inc | 2 | $58 |
| ABBVIE INC. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Electromed, Inc. | 1 | $40 |
| Seqirus USA Inc | 1 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
Products named: Ozempic, AIRSUPRA, TRINTELLIX, REXULTI, SMARTVEST, VRAYLAR, Fluad, JARDIANCE.
Industry payments across TN — which companies pay providers there.
